The American Diabetes Association has released the 2024 Standards of Care for people with Type 1 and Type 2 Diabetes. Join us as we talk with one of our favorite diabetes experts, Dr. Sue Cornell, about the major shifts in diabetes care that are omnipresent in this year’s guideline updates.

THE GAMECHANGER: Diabetes treatment is shifting to prevention and delay. After a long period of time without many advances, we are now on the brink of changing the game in diabetes care and prevention with new drugs and technologies.

Upon successful completion of this course, learners should be able to:
1. Discuss highlights of the 2024 American Diabetes Association Standards of Care Update
2. Describe the landscape of diabetes care as it shifts to prevention and delay

Geoffrey C. Wall, PharmD, FCCP, BCPS, CG
Professor of Clinical Sciences
Drake University College of Pharmacy and Health Sciences

Susan Cornell, PharmD, CDCES, FAPhA, FADCES
Diabetes Care & Education Specialist
Midwestern University College of Pharmacy

Dr. Wall is a member of the Janssen Speaker’s Bureau. All relevant financial relationships have been mitigated.  

Dr. Susan Cornell is an advisory board member for Novo Nordisk. All relevant financial relationships have been mitigated.

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Release Date: February 5, 2024
Planned Expiration Date: February 5, 2025

Copyright 2024, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.